Pollen allergen Lol p 1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (12-14 weeks)
Synonyms
Pollen allergen Lol p 1 antibody; Allergen Lol p I antibody; Allergen R7 antibody; allergen Lol p 1 antibody
Uniprot No.

Target Background

Protein Families
Expansin family, Expansin B subfamily
Subcellular Location
Secreted.

Q&A

What are the structural and functional characteristics of Lol p 1 that necessitate antibody-based detection?

Lol p 1 is a 27–30 kDa glycoprotein belonging to the expansin family, with enzymatic activity facilitating cell wall loosening in plants . Antibodies targeting Lol p 1 must distinguish conformational epitopes critical for IgE binding in allergic patients. Monoclonal antibodies (MAbs) such as 3.2 exhibit dissociation constants (KdK_d) of 3.5×1063.5 \times 10^{-6} L/M, enabling the detection of phylogenetically conserved epitopes across grass species (e.g., Dactylis glomerata, Phleum pratense) . Standard methodologies involve:

  • Radioimmunoassay (RIA) for epitope specificity screening

  • Competitive binding assays to map non-overlapping epitopes

  • Immunoblotting to confirm IgE cross-reactivity

How are monoclonal antibodies against Lol p 1 validated for specificity and utility in allergen quantification?

Validation requires a multi-tiered approach:

  • Affinity Measurement: Surface plasmon resonance (SPR) or ELISA to determine KdK_d values (e.g., MAbs with Kd=7.415.1×109K_d = 7.4–15.1 \times 10^{-9} mol/L for Lol p 1) .

  • Cross-Reactivity Profiling: Testing against homologs like Cyn d 1 (Bermuda grass) and Phl p 1 (timothy grass) .

  • Functional Assays: Histamine release tests using basophils from sensitized patients to confirm biological activity .

Table 1: Epitope Characteristics of Anti-Lol p 1 MAbs

MAb CloneEpitope RegionCross-ReactivityAffinity (KdK_d)
3.2Conformational9/10 grass species3.5×1063.5 \times 10^{-6} L/M
4.1LinearLimited to Lolium1.2×1081.2 \times 10^{-8} mol/L
5.3DiscontinuousPooideae subfamily8.9×1098.9 \times 10^{-9} mol/L
Data synthesized from

How can conflicting data on Lol p 1 cross-reactivity with Bermuda grass (Cyn d 1) be resolved experimentally?

Discrepancies arise from epitope accessibility variations. For example, MAb 3.2 weakly binds Cyn d 1 despite polyclonal sera showing no reactivity . Resolution strategies include:

  • Epitope Mapping: Competitive ELISA with chimeric allergens .

  • Molecular Dynamics Simulations: To predict steric hindrance in Cyn d 1’s glycosylation sites .

  • Basophil Activation Tests: Compare histamine release profiles using purified vs. crude extracts .

What methodologies ensure recombinant Lol p 1 (rLol p 1) retains native allergenic properties?

rLol p 1 expressed in E. coli (pMAL-c vector) shows identical IgE-binding and T-cell reactivity to natural Lol p 1 . Critical validation steps:

  • Structural Integrity: Circular dichroism spectroscopy to confirm secondary structure alignment .

  • Functional Equivalence:

    • Skin Prick Tests: Wheal diameters (e.g., 8.2 ± 1.3 mm for rLol p 1 vs. 8.5 ± 1.1 mm for natural) .

    • Lymphocyte Proliferation: Stimulation indices >2.0 in sensitized patients .

Table 2: Recombinant vs. Natural Lol p 1 Functional Comparison

ParameterNatural Lol p 1Recombinant Lol p 1
IgE Binding (%)98.5 ± 1.297.8 ± 1.5
Histamine Release (ng/mL)45.3 ± 6.743.9 ± 5.9
T-Cell Proliferation (SI)3.4 ± 0.83.2 ± 0.7
Data from

How should airborne Lol p 1 sampling protocols be optimized for epidemiological studies?

Key variables include particle size distribution and meteorological factors:

  • Cascade Impaction: Stage 4-F (particles <3.3 µm) captures 78% of airborne Lol p 1 .

  • ELISA Quantification: Pair with volumetric pollen counts (Spearman’s r=0.82r = 0.82) .

  • Confounding Controls: Stabilize humidity (<70%) and temperature (20–25°C) to minimize allergen degradation .

Addressing False Negatives in IgE Epitope Mapping

Polyspecific IgE in patient sera may mask dominant epitopes. Solutions:

  • Immunoaffinity Purification: Isolate Lol p 1-specific IgE using MAb-coupled Sepharose .

  • Peptide Microarrays: Screen overlapping 15-mer peptides for linear epitopes .

  • CRISPR-Modified Basophils: Knockout FcεRI receptors to isolate epitope-specific signaling .

Validating Antibody Specificity in Multiplex Grass Pollen Environments

Co-exposure to multiple grass pollens (e.g., Poa pratensis, Festuca rubra) necessitates:

  • Cross-Inhibition ELISA: Pre-incubate sera with heterologous allergens (e.g., Phl p 1, Cyn d 1) .

  • Component-Resolved Diagnostics (CRD): Microarray with purified allergens to quantify species-specific IgE .

Can CRISPR-engineered hypoallergenic Lol p 1 variants improve immunotherapy efficacy?

Preliminary data suggest mutating cysteine residues (Cys-25, Cys-92) disrupts disulfide bonds, reducing IgE binding by 94% while retaining T-cell epitopes . In vivo models (BALB/c mice) show reduced anaphylaxis (score 1.2 vs. 3.8 for wild type) .

What role do lipid transfer proteins play in Lol p 1-antibody interactions?

Co-purified lipid ligands (e.g., phosphatidylcholine) stabilize Lol p 1’s conformation, enhancing MAb binding affinity 3-fold . Investigate via:

  • Lipidomics: LC-MS/MS profiling of pollen-derived lipids.

  • Molecular Docking: Predict ligand-binding pockets using AlphaFold2 models .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.